With a market cap of $214.8 billion, Merck & Co., Inc. (MRK) is a research-driven biopharmaceutical company committed to using cutting-edge science to save and improve lives around the world. For more than 130 years, the company has advanced innovative medicines and vaccines while upholding its core values of integrity, respect for people, and putting patients first. Shares of the Rahway, New Jersey-based company have underperformed the broader market over the past 52 weeks. The stock has declined nearly ...